Track topics on Twitter Track topics that are important to you
BioNTech, the German developer of individualized treatments for cancer and other diseases that has raised more than $1 billion in capital as a privately-held company, has disclosed plans to go public by raising $100 million through an initial public offering.
The post BioNTech Plans Pipeline, Platform Expansion with IPO Proceeds appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Article: BioNTech Plans Pipeline, Platform Expansion with IPO ProceedsNEXT ARTICLE
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...